Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS
· Delayed Price · Currency is USD
8.50
0.00 (0.00%)
Inactive · Last trade price
on Oct 1, 2024
Eiger BioPharmaceuticals Market Cap
Eiger BioPharmaceuticals has a market cap or net worth of $12.59 million as of November 8, 2024. Its market cap has decreased by -68.90% in one year.
Market Cap
12.59M
Enterprise Value
-19.14M
Revenue
15.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.50
Market Cap Chart
Since March 23, 2016, Eiger BioPharmaceuticals's market cap has decreased from 111.23M to 12.59M, a decrease of -88.68%. That is a compound annual growth rate of -22.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 19.10B |
| Telix Pharmaceuticals Limited | 4.68B |
| Elekta AB (publ) | 2.54B |
| Ryman Healthcare Limited | 2.03B |
| Verano Holdings Corp. | 1.19B |
| Vireo Growth Inc. | 106.45M |
| Medexus Pharmaceuticals Inc. | 44.51M |